PRIZMAH Trademark

Trademark Overview

On Friday, August 18, 2017, a trademark application was filed for PRIZMAH with the United States Patent and Trademark Office. The USPTO has given the PRIZMAH trademark a serial number of 87574916. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 17, 2025. This trademark is owned by AK Pharma, Inc.. The PRIZMAH trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments, namely, platelet rich plasma extraction kit comprising syringes, blood component separation apparatus and sample tubes containing anticoagulant
prizmah

General Information

Serial Number87574916
Word MarkPRIZMAH
Filing DateFriday, August 18, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 17, 2025
Registration Number5716579
Registration DateTuesday, April 2, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a triangle design composed of identical circles that curve to the left side of the stylized word "PRIZMAH".
Goods and ServicesMedical apparatus and instruments, namely, platelet rich plasma extraction kit comprising syringes, blood component separation apparatus and sample tubes containing anticoagulant

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 17, 2025
Primary Code010
First Use Anywhere DateWednesday, June 3, 2015
First Use In Commerce DateWednesday, May 16, 2018

Trademark Owner History

Party NameAK Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiami, FL 33186
Party NameAK Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33186
Party NameAK Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33186

Trademark Events

Event DateEvent Description
Thursday, August 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 25, 2017NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, November 22, 2017ASSIGNED TO EXAMINER
Wednesday, November 22, 2017NON-FINAL ACTION WRITTEN
Friday, November 24, 2017NON-FINAL ACTION MAILED
Wednesday, March 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 28, 2018NOTICE OF PUBLICATION
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 12, 2018NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 9, 2018TEAS STATEMENT OF USE RECEIVED
Friday, September 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 13, 2019ABANDONMENT - DEFECTIVE USE STATEMENT
Wednesday, February 13, 2019ABANDONMENT NOTICE MAILED - DEFECTIVE USE STATEMENT
Friday, February 22, 2019TEAS STATEMENT OF USE RECEIVED
Friday, February 22, 2019TEAS PETITION TO REVIVE RECEIVED
Friday, February 22, 2019PETITION TO REVIVE-GRANTED
Friday, February 22, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Saturday, February 23, 2019NOTICE OF REVIVAL - MAILED
Wednesday, December 12, 2018SOU EXTENSION 1 FILED
Monday, February 25, 2019SOU EXTENSION 1 GRANTED
Friday, February 22, 2019USE AMENDMENT FILED
Monday, February 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 17, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

prizmah apparatus separation component blood sample tubes anticoagulant containing syringes comprising